Kingsview Wealth Management LLC Sells 189 Shares of Intuitive Surgical, Inc. $ISRG

Kingsview Wealth Management LLC reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,346 shares of the medical equipment provider’s stock after selling 189 shares during the period. Kingsview Wealth Management LLC’s holdings in Intuitive Surgical were worth $2,362,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. Nuveen LLC bought a new position in Intuitive Surgical during the 1st quarter valued at $1,715,899,000. Goldman Sachs Group Inc. increased its stake in shares of Intuitive Surgical by 26.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock worth $1,396,496,000 after purchasing an additional 584,375 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Intuitive Surgical by 20.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock valued at $1,680,922,000 after buying an additional 566,979 shares during the period. Jennison Associates LLC raised its stake in Intuitive Surgical by 20.4% in the 2nd quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock valued at $1,696,738,000 after acquiring an additional 528,359 shares during the period. Finally, Wellington Management Group LLP raised its position in shares of Intuitive Surgical by 15.0% in the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after purchasing an additional 457,080 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a report on Friday, October 31st. Piper Sandler increased their target price on shares of Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Jefferies Financial Group lifted their price target on Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research note on Wednesday, October 22nd. Wells Fargo & Company increased their price objective on Intuitive Surgical from $599.00 to $600.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Finally, Leerink Partners raised their price target on shares of Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $608.92.

Intuitive Surgical Stock Up 0.0%

Shares of NASDAQ ISRG opened at $546.77 on Wednesday. The firm’s 50-day moving average price is $485.63 and its 200-day moving average price is $503.34. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The company has a market cap of $196.00 billion, a PE ratio of 72.32, a PEG ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s revenue was up 22.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.84 earnings per share. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, CEO David J. Rosa sold 24,500 shares of the firm’s stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $547.55, for a total value of $13,414,975.00. Following the completion of the sale, the chief executive officer owned 234,256 shares in the company, valued at approximately $128,266,872.80. This trade represents a 9.47% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Brian Edward Miller sold 3,500 shares of the company’s stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the transaction, the executive vice president owned 5,758 shares in the company, valued at $3,310,850. The trade was a 37.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 116,164 shares of company stock worth $61,916,172 in the last quarter. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.